Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.

Chawla S, Kim S, Dougherty L, Wang S, Loevner LA, Quon H, Poptani H.

AJR Am J Roentgenol. 2013 Jan;200(1):35-43. doi: 10.2214/AJR.12.9432.

PMID:
23255739
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.

Ng SH, Lin CY, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Huang SF, Lin YC, Wang JJ.

PLoS One. 2013 Aug 7;8(8):e72230. doi: 10.1371/journal.pone.0072230. eCollection 2013.

PMID:
23951300
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.

Jansen JF, Schöder H, Lee NY, Stambuk HE, Wang Y, Fury MG, Patel SG, Pfister DG, Shah JP, Koutcher JA, Shukla-Dave A.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):299-307. doi: 10.1016/j.ijrobp.2010.11.022. Epub 2011 Jan 13.

PMID:
21236594
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, Fury MG, Patel SG, Moreira AL, Sherman E, Karimi S, Wang Y, Kraus D, Shah JP, Pfister DG, Koutcher JA.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1837-44. doi: 10.1016/j.ijrobp.2011.03.006. Epub 2011 May 19.

PMID:
21601373
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.

Choi HS, Kim AH, Ahn SS, Shin NY, Kim J, Lee SK.

Korean J Radiol. 2013 May-Jun;14(3):487-92. doi: 10.3348/kjr.2013.14.3.487. Epub 2013 May 2.

PMID:
23690718
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.

Srinivasan A, Chenevert TL, Dwamena BA, Eisbruch A, Watcharotone K, Myles JD, Mukherji SK.

J Comput Assist Tomogr. 2012 Jan-Feb;36(1):131-7. doi: 10.1097/RCT.0b013e3182405435.

PMID:
22261783
[PubMed - indexed for MEDLINE]
7.

Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.

King AD, Chow KK, Yu KH, Mo FK, Yeung DK, Yuan J, Bhatia KS, Vlantis AC, Ahuja AT.

Radiology. 2013 Feb;266(2):531-8. doi: 10.1148/radiol.12120167. Epub 2012 Nov 14.

PMID:
23151830
[PubMed - indexed for MEDLINE]
8.

Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.

Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A, Poptani H.

Clin Cancer Res. 2009 Feb 1;15(3):986-94. doi: 10.1158/1078-0432.CCR-08-1287.

PMID:
19188170
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.

Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.

J Magn Reson Imaging. 2009 Feb;29(2):341-9. doi: 10.1002/jmri.21650.

PMID:
19161186
[PubMed - indexed for MEDLINE]
10.

Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.

Notohamiprodjo M, Staehler M, Steiner N, Schwab F, Sourbron SP, Michaely HJ, Helck AD, Reiser MF, Nikolaou K.

Acad Radiol. 2013 Jun;20(6):685-93. doi: 10.1016/j.acra.2013.01.015.

PMID:
23664397
[PubMed - indexed for MEDLINE]
11.

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S.

J Nucl Med. 2009 Jul;50(7):1020-7. doi: 10.2967/jnumed.109.062638. Epub 2009 Jun 12.

PMID:
19525447
[PubMed - indexed for MEDLINE]
Free Article
12.

Apparent diffusion coefficient values of necrotic and solid portion of lymph nodes: differential diagnostic value in cervical lymphadenopathy.

Zhang Y, Chen J, Shen J, Zhong J, Ye R, Liang B.

Clin Radiol. 2013 Mar;68(3):224-31. doi: 10.1016/j.crad.2011.04.002. Epub 2012 Feb 7.

PMID:
22316593
[PubMed - indexed for MEDLINE]
13.

Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.

Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA.

J Magn Reson Imaging. 2009 Aug;30(2):327-34. doi: 10.1002/jmri.21824.

PMID:
19629981
[PubMed - indexed for MEDLINE]
14.

Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.

Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Vander Poorten V, Hauben E, Lambrecht M, Nuyts S, Hermans R.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1098-107. doi: 10.1016/j.ijrobp.2011.02.044. Epub 2011 Apr 20.

PMID:
21514067
[PubMed - indexed for MEDLINE]
15.

Usefulness of 3T diffusion-weighted MRI for discrimination of reactive and metastatic cervical lymph nodes in patients with oral squamous cell carcinoma: a pilot study.

Si J, Huang S, Shi H, Liu Z, Hu Q, Wang G, Shen G, Zhang D.

Dentomaxillofac Radiol. 2014;43(3):20130202. doi: 10.1259/dmfr.20130202. Epub 2014 Jan 22.

PMID:
24408820
[PubMed - indexed for MEDLINE]
16.

Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.

Kallehauge J, Nielsen T, Haack S, Peters DA, Mohamed S, Fokdal L, Lindegaard JC, Hansen DC, Rasmussen F, Tanderup K, Pedersen EM.

Acta Oncol. 2013 Oct;52(7):1360-8. doi: 10.3109/0284186X.2013.813637. Epub 2013 Sep 5.

PMID:
24003852
[PubMed - indexed for MEDLINE]
17.

Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, Chalian A, Poptani H.

AJNR Am J Neuroradiol. 2010 Feb;31(2):262-8. doi: 10.3174/ajnr.A1817. Epub 2009 Oct 1.

PMID:
19797785
[PubMed - indexed for MEDLINE]
Free Article
18.

Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.

Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A.

AJR Am J Roentgenol. 2011 Jan;196(1):210-7. doi: 10.2214/AJR.10.4258.

PMID:
21178069
[PubMed - indexed for MEDLINE]
19.

An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.

Wang P, Popovtzer A, Eisbruch A, Cao Y.

Med Phys. 2012 Aug;39(8):5277-85. doi: 10.1118/1.4737022.

PMID:
22894453
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy.

Kim KA, Park MS, Ji HJ, Park JY, Han KH, Kim MJ, Kim KW.

J Magn Reson Imaging. 2014 Feb;39(2):286-92. doi: 10.1002/jmri.24161. Epub 2013 Dec 2.

PMID:
24302545
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk